Paper12819086
Immune responses induced by the Leishmania (Leishmania) donovani A2 antigen, but not by the LACK antigen, are protective against experimental Leishmania (Leishmania) amazonensis infection.
Coelho EA and 9 others. Infect Immun, 2003. Cited by 215 papers, by iCite.
Cite this record
ConductScience Library. Immune responses induced by the Leishmania (Leishmania) donovani A2 antigen, but not by the LACK antigen, are protective against experimental Leishmania (Leishmania) amazonensis infection. Papers, record 12819086. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/12819086
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Immune responses induced by the Leishmania (Leishmania) donovani A2 antigen, but not by the LACK antigen, are protective against experimental Leishmania (Leishmania) amazonensis infection.
- PubMed
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antigens, Protozoan | Major topic |
| Leishmania donovani | Major topic |
| Leishmania mexicana | Major topic |
| Leishmaniasis, Cutaneous | Major topic |
| Protozoan Proteins | Major topic |
| Protozoan Vaccines | Major topic |
| Vaccines, Synthetic | Major topic |
| Animals | |
| Antibodies, Protozoan | |
| CD4-Positive T-Lymphocytes | |
| Female | |
| Immunization | |
| Immunoglobulin G | |
| Interferon-gamma | |
| Interleukin-10 | |
| Interleukin-4 | |
| Mice | |
| Mice, Inbred BALB C |
Source PubMed
References38
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 7545921 | Developmental gene expression in Leishmania donovani: differential cloning and analysis of an amastigote-stage-specific gene. | Mol Cell Biol | 1994 | https://conductscience.org/library/papers/7545921 | PubMed |
| 2 | 8358705 | Leishmaniases of the New World: current concepts and implications for future research. | Clin Microbiol Rev | 1993 | https://conductscience.org/library/papers/8358705 | PubMed |
| 3 | 7642292 | Leishmania pifanoi amastigote antigens protect mice against cutaneous leishmaniasis. | Infect Immun | 1995 | https://conductscience.org/library/papers/7642292 | PubMed |
| 4 | 8813679 | Identification and overexpression of the A2 amastigote-specific protein in Leishmania donovani. | Mol Biochem Parasitol | 1996 | https://conductscience.org/library/papers/8813679 | PubMed |
| 5 | 8832890 | Resistance to Leishmania major induced by tolerance to a single antigen. | Science | 1996 | https://conductscience.org/library/papers/8832890 | PubMed |
| 6 | 8864217 | Leishmania (V.) guyanensis: isolation and characterization of glucantime-resistant cell lines. | Can J Microbiol | 1996 | https://conductscience.org/library/papers/8864217 | PubMed |
| 7 | 9164958 | Role of CD4+ T cells in pathogenesis associated with Leishmania amazonensis infection. | J Immunol | 1997 | https://conductscience.org/library/papers/9164958 | PubMed |
| 8 | 9175832 | IL-4 rapidly produced by V beta 4 V alpha 8 CD4+ T cells instructs Th2 development and susceptibility to Leishmania major in BALB/c mice. | Immunity | 1997 | https://conductscience.org/library/papers/9175832 | PubMed |
| 9 | 9314562 | Vaccination with DNA encoding the immunodominant LACK parasite antigen confers protective immunity to mice infected with Leishmania major. | J Exp Med | 1997 | https://conductscience.org/library/papers/9314562 | PubMed |
| 10 | 9394518 | Immune responses induced by a Leishmania (Leishmania) amazonensis recombinant antigen in mice and lymphocytes from vaccinated subjects. | Rev Inst Med Trop Sao Paulo | 1997 | https://conductscience.org/library/papers/9394518 | PubMed |
| 11 | 9662025 | A2rel: a constitutively expressed Leishmania gene linked to an amastigote-stage-specific gene. | Mol Biochem Parasitol | 1998 | https://conductscience.org/library/papers/9662025 | PubMed |
| 12 | 9686177 | Aging and immunoglobulin isotype patterns in oral tolerance. | Braz J Med Biol Res | 1998 | https://conductscience.org/library/papers/9686177 | PubMed |
| 13 | 9716105 | Susceptibility and resistance to Leishmania amazonensis in H-2q syngeneic high and low antibody responder mice (Biozzi mice). | Scand J Immunol | 1998 | https://conductscience.org/library/papers/9716105 | PubMed |
| 14 | 9834101 | The IL-4 rapidly produced in BALB/c mice after infection with Leishmania major down-regulates IL-12 receptor beta 2-chain expression on CD4+ T cells resulting in a state of unresponsiveness to IL-12. | J Immunol | 1998 | https://conductscience.org/library/papers/9834101 | PubMed |
| 15 | 9846579 | Vaccine requirements for sustained cellular immunity to an intracellular parasitic infection. | Nat Med | 1998 | https://conductscience.org/library/papers/9846579 | PubMed |
| 16 | 10092078 | Presentation of the Leishmania antigen LACK by infected macrophages is dependent upon the virulence of the phagocytosed parasites. | Eur J Immunol | 1999 | https://conductscience.org/library/papers/10092078 | PubMed |
| 17 | 10377151 | CD4(+) T cells which react to the Leishmania major LACK antigen rapidly secrete interleukin-4 and are detrimental to the host in resistant B10.D2 mice. | Infect Immun | 1999 | https://conductscience.org/library/papers/10377151 | PubMed |
| 18 | 11567746 | Immunization with A2 protein results in a mixed Th1/Th2 and a humoral response which protects mice against Leishmania donovani infections. | Vaccine | 2001 | https://conductscience.org/library/papers/11567746 | PubMed |
| 19 | 11895981 | Early enhanced Th1 response after Leishmania amazonensis infection of C57BL/6 interleukin-10-deficient mice does not lead to resolution of infection. | Infect Immun | 2002 | https://conductscience.org/library/papers/11895981 | PubMed |
| 20 | 12151189 | Diagnosis of American visceral leishmaniasis in humans and dogs using the recombinant Leishmania donovani A2 antigen. | Diagn Microbiol Infect Dis | 2002 | https://conductscience.org/library/papers/12151189 | PubMed |
Cited by80
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 215 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42571703 | Dicentrine, an Aporphine Alkaloid From Ocotea langsdorffii, Induces Mitochondrial Dysfunction and Oxidative Stress in Leishmania (L.) infantum. | Chem Biodivers | 2026 | https://conductscience.org/library/papers/42571703 | PubMed |
| 42296080 | Comparison of a recombinant endonuclease III protein and its synthetic peptides in ELISA for the diagnosis of tegumentary leishmaniasis using human serum and urine samples: A preliminary study. | PLoS Negl Trop Dis | 2026 | https://conductscience.org/library/papers/42296080 | PubMed |
| 41908441 | Synthesis and Antileishmanial Activity of Cinnamic Acid-Amantadine Amides. | ACS Omega | 2026 | https://conductscience.org/library/papers/41908441 | PubMed |
| 40391226 | Blue light-emitting diode phototherapy presents in vitro efficacy against distinct Leishmania species and is therapeutic against tegumentary leishmaniasis in BALB/c mice. | Front Immunol | 2025 | https://conductscience.org/library/papers/40391226 | PubMed |
| 40160038 | An Update on Clinical and Pathogenic Spectra of Leishmaniasis. | Expert Rev Mol Med | 2025 | https://conductscience.org/library/papers/40160038 | PubMed |
| 39795229 | Exploring the Potential of Malvidin and Echiodinin as Probable Antileishmanial Agents Through In Silico Analysis and In Vitro Efficacy. | Molecules | 2025 | https://conductscience.org/library/papers/39795229 | PubMed |
| 39632642 | An update on recombinant vaccines against leishmaniasis. | Indian J Med Res | 2024 | https://conductscience.org/library/papers/39632642 | PubMed |
| 39604215 | Preclinical evaluation of immunogenicity and protective efficacy of a recombinant chimeric protein vaccine against visceral leishmaniasis. | Parasitology | 2025 | https://conductscience.org/library/papers/39604215 | PubMed |
| 38543905 | New Approaches to the Prevention of Visceral Leishmaniasis: A Review of Recent Patents of Potential Candidates for a Chimeric Protein Vaccine. | Vaccines (Basel) | 2024 | https://conductscience.org/library/papers/38543905 | PubMed |
| 38035118 | Development of a multi-epitope vaccine candidate for leishmanial parasites applying immunoinformatics and in vitro approaches. | Front Immunol | 2023 | https://conductscience.org/library/papers/38035118 | PubMed |
| 37768367 | Immunization with recombinant LiHyp1 protein plus adjuvant is protective against tegumentary leishmaniasis. | Parasitol Res | 2023 | https://conductscience.org/library/papers/37768367 | PubMed |
| 37631028 | Synthesis of 1,2,3-Triazole-Containing Methoxylated Cinnamides and Their Antileishmanial Activity against the Leishmania braziliensis Species. | Pharmaceuticals (Basel) | 2023 | https://conductscience.org/library/papers/37631028 | PubMed |
| 37372136 | Efficacy of an Immunotherapy Combining Immunogenic Chimeric Protein Plus Adjuvant and Amphotericin B against Murine Visceral Leishmaniasis. | Biology (Basel) | 2023 | https://conductscience.org/library/papers/37372136 | PubMed |
| 36839586 | Immunotherapy Using Immunogenic Mimotopes Selected by Phage Display plus Amphotericin B Inducing a Therapeutic Response in Mice Infected with Leishmania amazonensis. | Pathogens | 2023 | https://conductscience.org/library/papers/36839586 | PubMed |
| 36839574 | rMELEISH: A Novel Recombinant Multiepitope-Based Protein Applied to the Serodiagnosis of Both Canine and Human Visceral Leishmaniasis. | Pathogens | 2023 | https://conductscience.org/library/papers/36839574 | PubMed |
| 35891310 | A Recombinant Chimeric Protein-Based Vaccine Containing T-Cell Epitopes from Amastigote Proteins and Combined with Distinct Adjuvants, Induces Immunogenicity and Protection against Leishmania infantum Infection. | Vaccines (Basel) | 2022 | https://conductscience.org/library/papers/35891310 | PubMed |
| 35769465 | Major Molecular Factors Related to Leishmania Pathogenicity. | Front Immunol | 2022 | https://conductscience.org/library/papers/35769465 | PubMed |
| 35145518 | Temporary Shutdown of ERK1/2 Phosphorylation Is Associated With Activation of Adaptive Immune Cell Responses and Disease Progression During Leishmania amazonensis Infection in BALB/c Mice. | Front Immunol | 2022 | https://conductscience.org/library/papers/35145518 | PubMed |
| 35060464 | Diagnostic application of sensitive and specific phage-exposed epitopes for visceral leishmaniasis and human immunodeficiency virus coinfection. | Parasitology | 2021 | https://conductscience.org/library/papers/35060464 | PubMed |
| 34952558 | Vaccination in Leishmaniasis: A Review Article. | Iran Biomed J | 2022 | https://conductscience.org/library/papers/34952558 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/12819086
GET https://conductscience.org/api/papers/v1/12819086/references?page=2